Hernández-Alcaraz C, Shamah-Levy T, Romero-Martínez M, Sepúlveda-Amor J, Aguilar-Salinas CA, Rivera-Dommarco J, Kershenobich-Stalnikowitz D, Hernández-Ávila M, Barquera S

Language: Spanish
References: 21
Page: 504-510
PDF size: 248.75 Kb.

ABSTRACT

Objective. To describe the adult subsample for the analysis of biomarkers of chronic diseases, as well as the sample sizes (n) and representativity of the Encuesta Nacional de Salud y Nutrición (Ensanut) 2016. Materials and methods. An adult subsample with national representativity was calculated to obtain blood, serum and urine samples. The prevalence of variables of interest was compared for each subsample. Results. The n for at least one serum biomarker and urine samples were 4 000 and 3 782, respectively. The n varied depending on the grouping of biomarkers and fasting time selection. No differences were observed in the distribution of variables between the whole sample, urine and blood biomarkers samples. Conclusion. The weighted subsamples of urine, serum and blood biomarkers are comparable to the weighted sample of adults in the survey. The data of the subsample will allow to monitor the distribution of chronic diseases in Mexico, including altered function of liver and kidney, and sodium intake.

REFERENCES

1. Institute for Health Metrics and Evaluation. GBD Compare. Seattle, WA: IHME, 2015 [citado marzo 1, 2020]. Disponible en: http://vizhub. healthdata.org/gbd-compare

2. Gutiérrez G, Sepúlveda-Amor J, Tapia-Conyer R, Pérez-Heredia R, Solache-Alcaraz G, Valdespino JL. Encuesta Nacional Seroepidemiológica. I. Diseño conceptual y metodología. Salud Publica Mex. 1988;30(5):836-42 [citado marzo 1, 2020]. Disponible en: http://www.saludpublica.mx/index. php/spm/article/view/130

3. Tapia-Conyer R, Gutiérrez G, Sepúlveda J. Metodología de la Encuesta Nacional Seroepidemiológica, México. Salud Publica Mex. 1992;34(l):124- 35 [citado marzo 1, 2020]. Disponible en: http://saludpublica.mx/index. php/spm/article/view/5481/5827

4. Sepúlveda J, Tapia-Conyer R, Velásquez O. Diseño y metodología de la Encuesta Nacional de Salud 2000. Salud Publica Mex. 2007;49(supl 3):S427-32 [citado marzo 1, 2020]. Disponible en: http://saludpublica.mx/ index.php/spm/article/view/4781

5. Romero-Martínez M, Shamah-Levy T, Franco-Núñez A, Villalpando S, Cuevas-Nasu L, Gutiérrez JP, Rivera-Dommarco JA. [National Survey of Health and Nutrition 2012: design and coverage]. Salud Publica Mex. 2013;55(supl 2):S332-40 [citado marzo 1, 2020]. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036- 36342013000800033&lng=es

6. Ramírez-Silva I, Jiménez-Aguilar A, Valenzuela-Bravo D, Martinez-Tapia B, Rodríguez-Ramírez S, Gaona-Pineda EB, et al. Methodology for estimating dietary data from the semi-quantitative food frequency questionnaire of the Mexican National Health and Nutrition Survey 2012. Salud Publica Mex [Internet]. 2016 58(6):629-38 [citado marzo 1, 2020]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/28225939

7. Medina C, Jáuregui A, Campos-Nonato I, Barquera S. Prevalencia y tendencias de actividad física en niños y adolescentes: resultados de Ensanut 2012 y Ensanut MC 2016. Salud Publica Mex. 2018;60(3):263 [citado marzo 1, 2020]. Disponible en: http://www.saludpublica.mx/index.php/spm/ article/view/8819

8. Basto-Abreu A, Barrientos-Gutiérrez T, Rojas-Martínez R, Aguilar-Salinas CA, López-Olmedo N, De la Cruz-Góngora V, et al. Prevalencia de diabetes y descontrol glucémico en México: resultados de la Ensanut 2016. Salud Publica Mex. 2020;62:50-59. https://doi.org/10.21149/10752

9. Hernández-Alcaraz C, Aguilar-Salinas CA, Mendoza-Herrera K, Pedroza- Tobías A, Villalpando-Hernández S, Shamah-Levy T, et al. Dyslipidemia prevalence, awareness, treatment and control in Mexico: Results of the Ensanut 2012. Salud Publica Mex. 2020;62(2):137-46. https://doi. org/10.21149/10520

10. Barquera S, Carrion C, Campos I, Espinosa J, Rivera J, Olaiz-Fernandez G. Methodology of the fasting sub-sample from the Mexican Health Survey, 2000. Salud Publica Mex. 2007;49(suppl 3):1-7 [citado marzo 1, 2020]. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_ arttext&pid=S0036-36342007000900014&lng=es&tlng=en

11. Barquera S, Campos-Nonato I, Carrión-Rábago C, Villalpando S, López-Ridaura R, Rojas R, Aguilar-Santos CA. Methodology for the analysis of type 2 diabetes, metabolic syndrome and cardiovascular disease risk indicators in the Ensanut 2006. Salud Publica Mex. 2010;52(suppl 1):S4-10. https://doi.org/10.1590/s0036-36342010000700003

12. Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371(7):624-34. https://doi.org/10.1056/NEJMoa1304127

13. Afshin A, Sur PJ, Fay KA, Cornaby L, Ferrara G, Salama JS, et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393(10184):1958- 72. https://doi.org/10.1016/S0140-6736(19)30041-8

14. Romero-Martínez M, Shamah-Levy T, Cuevas-Nasu L, Méndez Gómez- Humarán I, Gaona-Pineda EB, Gómez-Acosta LM, et al. Diseño metodológico de la Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Salud Publica Mex. 2017;59(3):299-305. https://doi.org/10.21149/8593

15. Slot C. Plasma creatinine determination a new and specific jaffe reaction method. Scand J Clin Lab Invest. 1965;17(4):381-7. https://doi. org/10.3109/00365516509077065

16. Secretaría de Salud, Instituto Nacional de Salud Pública, Centro de Investigación en Evaluación y Encuestas. Encuesta Nacional de Salud y Nutrición MC 2016 [Internet]. México: Instituto Nacional de Salud Pública, 2016 [citado mayo 30, 2018]. Disponible en: https://ensanut.insp.mx/ encuestas/ensanut2016/descargas.php

17. Ji C, Sykes L, Paul C, Dary O, Legetic B, Campbell NRC, Cappuccio FP. Systematic review of studies comparing 24-hour and spot urine collections for estimating population salt intake. Rev Panam Salud Pública. 2012;32(4):307-5 [citado marzo 1, 2020]. Disponible en: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020- 49892012001000010&lng=en&nrm=iso&tlng=en

18. Koo H, Lee S-G, Kim J-H. Evaluation of random urine sodium and potassium compensated by creatinine as possible alternative markers for 24 hours urinary sodium and potassium excretion. Ann Lab Med. 2015;35(2):238. https://doi.org/10.3343/alm.2015.35.2.238

19. Méndez-Sánchez N, Zamarripa-Dorsey F, Panduro A, Purón-González E, Coronado-Alejandro EU, Cortez-Hernández CA, et al. Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions. World J Clin Cases. 2018;6(15):922-30. https://doi.org/10.12998/ wjcc.v6.i15.922

20. Rivera-Dommarco J, Colchero M, Fuentes M, González de Cosio Martínez T, Aguilar Salinas C, Hernández Licona G, et al. Obesidad en México. Estado de la política pública y recomendaciones para su prevención y control. Cuernavaca, Morelos: Instituto Nacional de Salud Pública, 2018.

21. Reséndiz-Escobar E, Bustos-Gamino MN, Mujica-Salazar R, Soto- Hernández IS, Cañas-Martínez V, Fleiz-Bautista C, et al. National trends in alcohol consumption in Mexico: results of the National Survey on Drug, Alcohol and Tobacco Consumption 2016-2017. Salud Ment. 2018;41(1):7- 16. https://doi.org/10.17711/SM.0185-3325.2018.003